Edwards Lifesciences Corporation Common Stock vs Nexgen Energy Ltd. Common Shares — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Nexgen Energy Ltd. Common Shares trades at $8.69 (market cap $6.04B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 8.2× Nexgen Energy Ltd. Common Shares's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Nexgen Energy Ltd. Common Shares nearer its low. Which is the better fit depends on your goals.
| EW | NXE | |
|---|---|---|
Market Cap | $49.44B | $6.04B |
Volume | 3,508,027 | 4,194,158 |
Sector | Health | Energy |
52-Week High | $95.18 | $13.92 |
52-Week Low | $72.65 | $7.56 |
Enterprise Value | $45.90B | $5.79B |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →